A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
Thousands of plaintiffs have sued Ozempic manufacturers for failing to warn them about the risk of stomach paralysis.
The panel agreed with the FDA that the treatment in which a patient's tissue is processed doesn't fall under the same ...
Dupixent may help some people with inadequately controlled COPD who have a type of lung inflammation that worsens symptoms.
The U.S. Food and Drug Administration reports a pet food company is voluntarily withdrawing some of their beef and chicken ...
Manufacturers of the most accurate home COVID-19 tests on the market say they were left out again from the Biden ...
Despite billions of taxpayer dollars spent on mental illness research, Cobenfy was developed by a private biopharmaceutical ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
The FDA claimed these clinics were plying patients with an illegal drug derived from their stem cells. A federal court agrees ...
PTC518 was granted Fast Track designation based off strong 12-month interim data on safety and efficacy.
The U.S. Food and Drug Administration approved GE HealthCare's diagnostic drug for use in detection of coronary artery ...
Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback